Frontlight ResearchEarly access
CompletedNo phase
Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan
Key facts
- Who runs it
- Sohag University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 89 people enrolled
- Started
- 25 Apr 2023
- Ended
- 30 Jun 2024
- Type of study
- Observational, 3 groups
- Record updated
- 12 August 2024
Who can take part
- Age
- 20 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All included patients will be euthyroid, and stable on the same L T4 dose for at least 3 months before the start of Ramadan
Who cannot take part
- Exclusion criteria will be thyroid cancer patients requiring suppressive therapy, central hypothyroidism, pregnancy, coronary heart disease, arrythmia, chronic heart failure, liver cirrhosis, renal failure, acute medical, or surgical illness at the time of evaluation to avoid acute and chronic non thyroidal illness syndromes
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a study aiming to report the effect of a variable time regimen of L T4 during Ramadan, as an easier alternative, on adherence and thyroid status after Ramadan compared to standard daily dosing.
The 3 groups in the trial
- Group 1
.patients who will switch to twice weekly dosing. Their weekly dose was divided equally into those doses, given at successive fixed days of the week
- Group 2
patients who will switch to once-weekly dosing.
- Group 3
patients who will continue to take L T4 on a standard daily basis.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 12 August 2024